RECRUITING
I'm interested ...!!
Immediate Postpartum Glucose Tolerance Testing
The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.
Conditions:
🦠 Gestational Diabetes
🗓️ Study Start (Actual) 1 September 2020
🗓️ Primary Completion (Estimated) 1 January 2025
✅ Study Completion (Estimated) 1 July 2025
👥 Enrollment (Estimated) 300
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Long Beach, California, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Pregnant or recently postpartum (postpartum day 0 or 1)
    • * ≥ 18 years of age
    • * Gestational age ≥34 weeks
    • * A1 or A2 gestational diabetes

    Exclusion Criteria:

    • * Medical exclusion from completing glucose tolerance testing
    • * Steroid administration within 10 days prior to enrollment
    • * Chronic steroid use
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 12 December 2019
  • First Submitted that Met QC Criteria 12 December 2019
  • First Posted 16 December 2019

Study Record Updates

  • Last Update Submitted that Met QC Criteria 22 April 2024
  • Last Update Posted 24 April 2024
  • Last Verified April 2024
I'm interested ...!!